Mostrar el registro sencillo del ítem

dc.contributor.authorRisco Risco, Carlos
dc.contributor.authorHerrador, Zaida
dc.contributor.authorLópez Perea, Noemí
dc.contributor.authorMartínez Urbistondo, Diego
dc.contributor.authorSuárez del Villar, Rafael
dc.contributor.authorMasa-Calles, Josefa
dc.date.accessioned2026-02-20T17:16:01Z
dc.date.available2026-02-20T17:16:01Z
dc.date.issued2023
dc.identifier.citationRisco, C., Herrador, Z., López-Perea, N., Martínez-Urbistondo, D., Suárez del Villar Carrero, R., & Masa-Calles, J. (2023). Epidemiology of herpes zoster in the pre-vaccination era: establishing the baseline for vaccination programme’s impact in Spain. Eurosurveillance, 28(8), 2200390. https://doi.org/10.2807/1560-7917.ES.2023.28.8.2200390es
dc.identifier.issn1560-7917
dc.identifier.urihttp://hdl.handle.net/20.500.12020/1934
dc.description.abstractA nationwide retrospective study based on the Spanish National Health System Hospital Discharge Database analysed 65,401 herpes zoster (HZ)-related hospitalisations between 1998 and 2018. The mean annual hospitalisation rate was 6.75 per 100,000 population, with a significant increasing trend over time, particularly in individuals aged ≥65 years. Male sex and immunocompromising conditions were associated with higher severity. Leukaemia/lymphoma and solid malignant neoplasm showed the highest adjusted risk ratios for readmission and mortality, while HIV infection was also independently associated with fatal outcome. This study establishes a national baseline prior to the progressive implementation of recombinant zoster vaccination in Spain, providing essential epidemiological data for future effectiveness assessments and public health planning.es
dc.language.isoenes
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)es
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleEpidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spaines
dc.typearticlees
dc.identifier.doihttps://doi.org/10.2807/1560-7917.ES.2023.28.8.2200390
dc.issue.number8es
dc.journal.titleEurosurveillancees
dc.page.initial2200390es
dc.page.final2200390es
dc.rights.accessRightsopenAccesses
dc.subject.areaCiencias Biomédicases
dc.subject.areaCiencias de la Naturalezaes
dc.subject.keywordHerpes zosteres
dc.subject.keywordEpidemiologyes
dc.subject.keywordHospitalisationes
dc.subject.keywordVaccination policyes
dc.subject.keywordPublic healthes
dc.subject.keywordSpaines
dc.subject.keywordImmunocompromised populationses
dc.subject.unesco3205 Medicina Internaes
dc.subject.unesco3210 Medicina Preventivaes
dc.subject.unesco3207 Patologíaes
dc.subject.unesco3212 Salud Publicaes
dc.volume.number28es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional